|
SDHD expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.68500000513805E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
3.059700E-02 |
| Stage1-vs-Stage3 |
2.365700E-02 |
| Stage1-vs-Stage4 |
1.87166999999766E-05 |
| Stage2-vs-Stage3 |
1.536180E-03 |
| Stage2-vs-Stage4 |
2.49279999999796E-05 |
| Stage3-vs-Stage4 |
7.059600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.92119653519285E-11 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
6.719200E-01 |
| Caucasian-vs-Asian |
3.720400E-01 |
| AfricanAmerican-vs-Asian |
9.516600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
3.338000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(81-100Yrs) |
7.07960001733454E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.434000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.713200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.595000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.754000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.270200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.702400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.775700E-02 |
| Classical-VS-Follicular |
2.21970000002791E-06 |
| Classical-VS-Other |
8.527800E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
5.41369999940144E-08 |
| Tall-VS-Other |
2.250800E-01 |
| Tall-VS-Normal |
1.11022302462516E-16 |
| Follicular-VS-Other |
1.769410E-01 |
| Follicular-VS-Normal |
3.0237999881777E-09 |
| Other-VS-Normal |
5.22060000007762E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.182890E-04 |
|
|
